The influence of cardiac resynchronization therapy on prognosis and functional status of blood circulatory system at patients with mild chronic heart failure
FDA expedited access pathway enables staged approval opportunity for baroreflex activation therapy for heart failure with reduced ejection fraction: the BeAT-HF trial